Endocyte Inc. (ECYT) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 7:11 PM

Endocyte Inc. (ECYT) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on ECYT
Merck, Endocyte halt study of ovarian cancer drug 8:32 a.m. May 2, 2014 - MarketWatch.com
Charting the April cross currents 11:20 a.m. April 10, 2014 - Michael Ashbaugh
Six charts to watch for upside moves 12:33 p.m. March 28, 2013 - The Trading Deck
J&J to supply additional Doxil for clinical trials 11:16 a.m. Aug. 2, 2012 - MarketWatch.com
Endocyte shares extend gains in after-hours trade 4:50 p.m. April 16, 2012 - Carla Mozee
Stocks to watch Tuesday: Coke, Goldman Sachs 4:32 p.m. April 16, 2012 - David B. Wilkerson
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Endocyte soars 101% on Merck deal 10:43 a.m. April 16, 2012 - Val Brickates Kennedy
Merck to pay Endocyte up to $1 bln for cancer drug 6:57 a.m. April 16, 2012 - MarketWatch.com
Endocyte rockets 60% on EU update 12:09 p.m. March 14, 2012 - Val Brickates Kennedy
Endocyte plunges on drug study results 11:48 a.m. Dec. 13, 2011 - Val Brickates Kennedy
LinkedIn's surge sparks valuation questions 1:28 p.m. May 19, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:00 p.m. April 26, 2011 - Kate Gibson

Other News on ECYT
Can Endocyte (ECYT) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape 8:46 a.m. Today - Zacks.com
10-Q: ENDOCYTE INC 4:09 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% - Tale of the Tape 9:18 a.m. Nov. 7, 2014 - Zacks.com
Endocyte's (ECYT) CEO Ron Ellis on Q3 2014 Results - Earnings Call Transcript 10:52 p.m. Nov. 5, 2014 - Seeking Alpha
Endocyte (ECYT) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 5, 2014 - Seeking Alpha
Notable earnings after Wednesday’s close 5:35 p.m. Nov. 4, 2014 - Seeking Alpha
Will Endocyte (ECYT) Miss This Earnings Season? - Analyst Blog 4:50 p.m. Nov. 4, 2014 - Zacks.com
Endocyte's vintafolide shows mixed results in Phase 2 trial 5:45 p.m. Oct. 1, 2014 - Seeking Alpha
Why Endocyte (ECYT) Stock Is Declining Today 11:44 a.m. Sept. 30, 2014 - TheStreet.com
Brean Capital Downgrades Endocyte To Hold 7:34 a.m. Sept. 30, 2014 - benzinga.com
Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog 5:25 p.m. Sept. 29, 2014 - Zacks.com
Heavy Trading On Endocyte (ECYT) Before Market Open 8:32 a.m. Sept. 29, 2014 - TheStreet.com
Endocyte (ECYT) Flagged As Strong On High Volume 10:01 a.m. Sept. 23, 2014 - TheStreet.com
Palo Alto Networks Adds Stanley J. Meresman To Its Board 3:04 p.m. Sept. 22, 2014 - benzinga.com
Endocyte (ECYT) Showing Signs Of A Dead Cat Bounce Today 9:55 a.m. Sept. 19, 2014 - TheStreet.com
Top Swing Trade Ideas for Monday: Cerus, Endocyte, More 10:02 a.m. Sept. 15, 2014 - TheStreet.com
Endocyte (ECYT) Showing Signs Of A Dead Cat Bounce Today 10:08 a.m. Sept. 12, 2014 - TheStreet.com
Endocyte (ECYT) Showing Signs Of Perilous Reversal Today 9:46 a.m. Sept. 11, 2014 - TheStreet.com
Strength Seen in Flexion Therapeutics (FLXN): Stock Soars 17.8% - Tale of the Tape 9:46 a.m. Sept. 11, 2014 - Zacks.com
Aradigm Corporation (ARDM) Up: Stock Adds 9.7% in Session - Tale of the Tape 9:32 a.m. Sept. 11, 2014 - Zacks.com

Press Releases on ECYT
Endocyte Reports Third Quarter Financial Results and Provides Clinical Update 4:02 p.m. Nov. 5, 2014 - GlobeNewswire
Endocyte to Present at the 2014 Credit Suisse Healthcare Conference 4:04 p.m. Nov. 4, 2014 - GlobeNewswire
Endocyte Announces Third Quarter 2014 Earnings Conference Call 3:03 p.m. Oct. 29, 2014 - GlobeNewswire
Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte 8:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide 9:15 a.m. Sept. 27, 2014 - GlobeNewswire
Endocyte Announces Late-Breaking Abstract Presentation at the European Society for Medical Oncology (ESMO) Conference 3:02 p.m. Sept. 22, 2014 - GlobeNewswire
Critical Alerts For Weibo, Williams Companies, Endocyte, Boulder Brands and Randgold Resources Released By InvestorsObserver 8:31 a.m. Sept. 10, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry - Zoetis, Actavis, Horizon Pharma, Hospira, and Endocyte 7:55 a.m. Sept. 9, 2014 - PR Newswire - PRF
Endocyte to Present at the Baird 2014 Health Care Conference 3:02 p.m. Aug. 27, 2014 - GlobeNewswire
UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Endocyte, Inc. and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 9:31 a.m. Aug. 20, 2014 - GlobeNewswire
Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., EVOQ Properties Inc., Fortegra Financial Corporation, Intervest Bancshares Corporation and L-3 Communications Holdings, Inc. 12:52 p.m. Aug. 18, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Endocyte, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ECYT 12:49 p.m. Aug. 18, 2014 - GlobeNewswire
ENDOCYTE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endocyte, Inc. -- ECYT 9:00 p.m. Aug. 14, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Endocyte, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 4:47 p.m. Aug. 13, 2014 - GlobeNewswire
Endocyte Announces Presentations at the 248th American Chemical Society National Meeting & Exposition 3:04 p.m. Aug. 7, 2014 - GlobeNewswire
Endocyte to Present at Wedbush 2014 Life Sciences Management Access Conference 3:02 p.m. Aug. 5, 2014 - GlobeNewswire
Lieff Cabraser Announces Class Action Litigation Against Endocyte, Inc. - ECYT 2:54 p.m. Aug. 1, 2014 - BusinessWire - BZX
Critical Alerts For Aegerion Pharmaceuticals, ZELTIQ Aesthetics, Endocyte, Broadcom, and AstraZeneca Released By InvestorsObserver 8:31 a.m. July 31, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In Endocyte, Inc. To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit 3:59 p.m. July 30, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Endocyte, Inc. and a Lead Plaintiff Deadline of August 25, 2014 -- ECYT 4:55 p.m. July 29, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Deception Challenges the Confidence of Fraud Defenses

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Business Boom in 2026: Key Regions to Watch Now

Business Formations Break Records in 2026 I'm telling you, the entrepreneurial spirit is alive and kicking across the States this year. The latest numbers from Registered Agents Inc are clear as day: business is bustling. We're looking at 576,818 new business setups nationwide just in October 2026. That's outpacing the previous year by a whopping 8%. And if that doesn't...

Morgan County, IN: An Oasis for Balanced Living

Why Morgan County? A Question for Homebuyers Ever wondered what makes Morgan County, IN, such a hot ticket for folks looking to escape the daily grind of big city life? Rachel Blacklidge, real estate wizard and hometown hero, lays it all out in a way even the most city-bound among us can appreciate. Small-Town Vibes, Big-City Access Let’s face it—sometimes the chaos...

Accuray Finishes Key Deal, Resetting Financial Trajectory

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

TagMaster To Acquire Kapsch's RFID Ops in NA Market

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

PangeAI and Sky Blue Transform Data Center Decisions

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Betterness Expands Health Networks with $3.5M Boost

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Later's NYC Summit Reinvents Social Commerce Game Plan

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

KeyCorp Plans Redemption of Series E Preferred Stock

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...